How Five UChicago Innovators Are Fighting the IP Gender Gap
Four Startups Advance to Spring 2023 George Shultz Innovation Fund Finals
2 Startups Awarded $175,000 Each to Further Develop Cancer Treatment Technologies
Riptide Therapeutics Awarded $175,000 From George Shultz Innovation Fund
Alnair Therapeutics Awarded $175,000 From George Shultz Innovation Fund
UChicago, Duality Teams to Pitch at 2021 Chicago Venture Summit
Esya Labs and HeioThera Receive $250,000 Investment from the George Shultz Innovation Fund
Esya Labs Supports Drug Discovery Efforts at Novartis: ‘This is Only the Beginning,’ says CEO
Polsky Launches DeepTechU to Connect Investors with Faculty Startups in Deep Tech
Esya Labs Leads Paradigm Shift in Alzheimer’s Using Novel Biomarkers and AI for Revolutionary 360° Perspective of Disease
This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.